Biomarkers: Technologies and Global Markets

Report Code: BIO061C

Publish Date: Apr 2014

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global biomarkers market is expected to grow from $29.3 billion in 2013 to $53.6 billion in 2018, a compound annual growth rate (CAGR) of 12.8%.

Report Includes

  • An overview of the global market for biomarkers.
  • Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Assessments of companies poised to introduce products during the forecast period and discussion on how these introductions will change the face of the competitive environment.
  • A range of information from detailed product analyses within disease subsegments to overall industry trends.
  • A look at how market growth is expected in emerging geographies, driven by the growing middle class in emerging countries such as India, China, Brazil, and Russia.
  • Comprehensive profiles of manufacturers of leading products as well as biotechnology companies with novel products in development.

Report Scope

Current and projected product forecasts during the forecast period (2013 to 2018) are discussed. In addition, new products approved in 2012 and 2013 by the FDA, and those products expected to be approved within the forecast period, are projected. Figures are estimated for 2013, except where actual results have been reported, due to the timing of the release of the report. For all areas, including very large markets segments such as infectious disease and cardiovascular, specific mechanisms of action are discussed in detail. Market figures include the bundled value of the drug and the biomarker as it is impossible to quantitate the composite values of each.

The report includes an analysis of leading and emerging competitors in the current worldwide biomarkers market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define their specific product strategies. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care. Detailed profiles of current market leaders are discussed, as well as companies with innovative products poised to advance within the forecast period.

Market figures are based on revenues at the manufacturers’ level and are projected at 2013-dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products and projected changes in the prevalence, diagnosis and scripting rates for certain diseases.

Included in this report are forecasts by product, product category and by company from 2013 through 2018. The study is arranged to offer an overview of the biomarkers market accompanied by product, company, geography and mechanism of action with forecasts broken down and covered by geographic region or country. Virtually the entire globe is covered to include prevalence data for each disease subsegment.

Excluded from this report are over-the-counter (OTC) medications and other consumables that do not require a physician’s prescription.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.

All market share data presented is on a global basis, unless specifically noted.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development. Jackson Highsmith is a pseudonym of the author.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Biomarkers: Technologies and Global Markets169Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW22Free
Chapter- 4: REGULATORY DYNAMICS, INTELLECTUAL PROPERTY AND ETHICAL CONSIDERATIONS42Free
Chapter- 5: APPLICATION BY THERAPY AREA41Free
Chapter- 6: BIOMARKERS ACTIVELY GUIDING DRUG DEVELOPMENT16Free
Chapter- 7: COMPANY ANALYSIS41Free

Related Reports

Cancer Profiling and Pathways: Technologies and Global Markets

Published - Jan 2014 | Publisher - Usha Nagavarapu | Code - BIO073B

The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018, a compound annual growth rate (CAGR) of 12.8% over the five-year period, 2013 to 2018.

2013 Biotechnology Research Review

Published - Dec 2013 | Publisher - Various Analysts | Code - BIO069E

This BCC Research review provides highlights from biotechnology market research reports published in 2013. It covers topics like RNAi technologies, next generation sequencing and emerging clinical applications, bioinformatics, metabolomics, and protein drugs.

Companion Diagnostics: Technologies and Markets

Published - Nov 2013 | Publisher - Marianna Tcherpakov | Code - BIO077B

The global companion diagnostics market reached $1.1 billion in 2012. The market is expected to grow to $1.2 billion in 2013 and $3.5 billion in 2018 with a compound annual growth rate (CAGR) of 23.9%.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Published - Mar 2013 | Publisher - Jackson Highsmith | Code - BIO074B

The global CNS biomarker market was estimated at $1.7 billion in 2011 and nearly $2 billion in 2012. The market is projected to reach $5.1 billion by the end of the forecast period of 2012 to 2017, representing a compound annual growth rate (CAGR) of 20.7%.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 50

  • Summary Table: GLOBAL BIOMARKERS FORECAST BY SEGMENT, THROUGH 2018
  • Table 1: GLOBAL MARKET FOR BIOMARKERS, THROUGH 2013
  • Table 2: NOVEL SAFETY/TOXICOLOGY BIOMARKERS USED IN CANCER, CARDIO AND RENAL
  • Table 3: NOVEL DOSE SELECTION BIOMARKERS USED IN CANCER, DIABETES, METABOLIC AND LIVER DISEASE
  • Table 4: PATIENT OUTCOME MEASUREMENTS BIOMARKERS
  • Table 5: GLOBAL MARKET FOR BIOMARKERS, 2013
  • Table 6: GLOBAL BIOMARKER MARKET FORECAST, THROUGH 2018
  • Table 7: FDA GUIDELINES FOR BIOMARKER APPLICATIONS
  • Table 8: ANNUAL PATENTS FILED AND APPROVED WITH BIOMARKER CLAIMS IN THE U.S., EUROPE AND JAPAN, THROUGH 2013
  • Table 9: CURRENT GLOBAL MARKET FOR TOTAL CLINICAL STAGE BIOMARKERS BY SERVICES AND PRODUCTS, THROUGH 2018
  • Table 10: SUMMARY OF RECENT AGREEMENTS IN BIOMARKER DELIVERY, 2007-2013
Sample Report

Recent Reports

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO269A

The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

Global DNA Forensics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO266A

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

Global Blood Platelet Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO268A

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

Digital Biomarkers: Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO227B

The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.

Whole Genome Sequencing: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO271A

The global market for whole genome sequencing is expected to grow from $3 billion in 2025 and forecast to reach $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - IAS006Q

The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Water and Wastewater Treatment Technologies: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - ENV008G

The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Published - Mar-2011| Analyst - Jackson Highsmith| Code - BIO061B

Report Highlights

In 2010, the total global market for biomarkers was an estimated $13.5 billion and is expected to grow to nearly $33.3 billion by the end of 2015 at a 5-year compound annual growth rate (CAGR) of 19.8%.

Published - Nov-2007| Analyst - Vanita Khetan| Code - BIO061A

Report Highlights

  • The global market for biomarkers increased from $4.8 billion in 2006 to an estimated $5.6 billion by the end of 2007. It should reach $12.8 billion by 2012, a compound annual growth rate (CAGR) of 18%.
  • Global revenues for biomarker discovery technologies tailored to drug discovery, preclinical studies of drug development and diagnostics research applications accounted for 47.9% of the total market in 2007. Their value is projected to grow at a CAGR of 16.9% and is expected to reach a little less than $6 billion in 2012.
  • The use of biomarkers in oncology therapeutics is likely to be one of the foremost priorities in clinical trials in the next 3 to 7 years followed by cardiovascular applications.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Biomarkers: Technologies and Global Markets
Customize Report
AI: Your Say